FOLISURGE

This brand name is authorized in Nigeria.

Active ingredients

The drug FOLISURGE contains one active pharmaceutical ingredient (API):

1	Follitropin alfa UNII VV3HN9ZPB5 - FOLLITROPIN ALFA
	In women, the most important effect resulting from parenteral administration of FSH is the development of mature Graafian follicles.
	Read more about Follitropin alfa

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A6-0509	Solution for injection	Folisurge 75 IU Injection INJ_SOL 75 IU/0.12 mL 0.12 mL x 1's (in vial)	Solution for Injection in vial. Follitropin alfa is presented as a clear, colourless solution for injection in single-dose vial	31/07/2024
A6-0510	Solution for injection	Folisurge 1200 IU Injection INJ_SOL 1200 IU/1.92 mL 1.92 mL x 1's (in vial)	Solution for Injection in vial. Follitropin alfa is presented as a clear, colourless solution for injection in multi-dose vial	31/07/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03GA05	Follitropin alfa	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins
Discover more medicines within G03GA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A6-0509, A6-0510